Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2010
12/14/2010CA2192678C Mn gene and protein
12/09/2010WO2010141946A1 Peptide-coated cell localization to diseased or damaged tissues and methods related thereto
12/09/2010WO2010141918A1 Serum amyloid p derivatives and their preparation and use
12/09/2010WO2010141879A2 Peptides for transport of therapeutics and their carriers in mouse models and humans
12/09/2010WO2010141877A1 Method of treating stem cells
12/09/2010WO2010141866A2 Soga polynucleotides and polypeptides and uses thereof
12/09/2010WO2010141845A2 Immunoregulatory peptides and methods of use
12/09/2010WO2010141842A2 Interlaced method for treating cancer or a precancerous condition
12/09/2010WO2010141811A2 Compounds and methods for treating bone disorders and controlling weight
12/09/2010WO2010141810A2 Compositions and methods modulating mg29 for the treatment of diabetes
12/09/2010WO2010141760A2 Antimicrobial peptides
12/09/2010WO2010141685A1 Peptides and peptide compositions having osteoinductive activity
12/09/2010WO2010141609A1 Use of angiotensin converting enzyme (ace) domain specific inhibitors to inhibit or enhance cytokine production and alter immune response
12/09/2010WO2010141588A1 Ophthalmic oil-in-water emulsions containing cyclosporine or a polyphenol
12/09/2010WO2010141586A2 Therapeutic ophthalmic emulsions
12/09/2010WO2010141485A1 Compositions and methods to induce differentiation and growth inhibition in breast cancer
12/09/2010WO2010141349A1 Soluble guanylyl cyclase a1 and a-8r peptide as diagnostic markers of and therapeutic targets for prostate cancer
12/09/2010WO2010141329A1 Molecules with extended half-lives and uses thereof
12/09/2010WO2010141312A2 Flagellin fusion proteins and conjugates comprising pneumococcus antigens and methods of using the same
12/09/2010WO2010141143A2 Engineered avirulent bacteria strains and use in medical treatments
12/09/2010WO2010141097A2 Pegylated human apoa-1 and process for production thereof
12/09/2010WO2010141093A2 Co-signaling methods for treating cancers
12/09/2010WO2010141068A1 Opthalmic compositions of cyclosporin
12/09/2010WO2010140926A1 Stimulator of genital, sexual and reproductive function
12/09/2010WO2010140886A1 Method for enhancing phagocytosis of phosphatidylserine-exposing cells
12/09/2010WO2010140685A1 Heterocyclic compound and hematopoietic stem cell amplifier
12/09/2010WO2010140567A1 Endokinin c/d-origin peptides
12/09/2010WO2010140531A1 Pharmaceutical composition, food or beverage, and methods for these products
12/09/2010WO2010140435A1 Β-galactosidase derived from bacillus circulans
12/09/2010WO2010140401A1 Microneedle array using porous substrate and process for producing same
12/09/2010WO2010140060A2 Peptide synthesis
12/09/2010WO2010139741A1 Fgf-21 for treating cancers
12/09/2010WO2010139539A1 Pharmaceutical compositions containing antifungal peptides
12/09/2010WO2010139442A1 Improved reconstituted surfactant composition containing analogs of surfactant protein b (sp-b) and surfactant protein c (sp-c)
12/09/2010WO2010139401A1 Method for cancer therapy based on co-administration of a parvovirus and a cytokine
12/09/2010WO2010139075A1 Synthesis and use of radiolabelled insulin analogues
12/09/2010WO2010139063A1 Diagnosis of restenosis in patients undergoing percutaneous coronary intervention
12/09/2010WO2010139048A1 Human milk peptides
12/09/2010WO2010120476A3 N-terminus conformationally constrained glp-1 receptor agonist compounds
12/09/2010WO2010089122A3 Vector(s) containing an inducible gene encoding a cdk4/cdk6 inhibitor useful for treating neurodegenerative disorders or diseases associated with an unscheduled activation of the cell cycle
12/09/2010WO2010085086A3 Modified human thrombopoietin polypeptide fragment and manufacturing method thereof
12/09/2010WO2010083239A3 Therapeutic modulation of vaginal epithelium boundary lubrication
12/09/2010WO2010011313A3 Ligation of stapled polypeptides
12/09/2010WO2010000801A3 Whey protein hydrolysate containing tryptophan peptide consisting of alpha lactalbumin and the use thereof
12/09/2010WO2009147326A8 Analgesic effects of peptide toxin apetx2
12/09/2010US20100313300 Weed controller metabolism proteins, genes, thereof and use of the same
12/09/2010US20100313283 Uses of gdnf and gdnf receptor
12/09/2010US20100311944 Cyclosporine analogue mixtures and their use as immunomodulating agents
12/09/2010US20100311824 Modulation of forkhead box o1a expression
12/09/2010US20100311822 ACE2 Activation For Treatment Of Heart, Lung and Kidney Disease and Hypertension
12/09/2010US20100311813 Antiandrogen oligonucleotides usable for the treatment of dermatological androgen-related disorders relating to androgen metabolism, their pharmaceutical compositions, their uses and treatment method
12/09/2010US20100311812 RNA INTERFERENCE MEDIATED INHIBITION OF INTERCELLULAR ADHESION MOLECULE (ICAM) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
12/09/2010US20100311705 Ophthalmologic irrigation solutions and method
12/09/2010US20100311672 Vesiculins
12/09/2010US20100311671 Transdermal delivery of pkc modulatory peptides through microporated skin
12/09/2010US20100311670 Conjugates of hydroxyalkyl starch and a protein, prepared by native chemical ligation
12/09/2010US20100311669 Compounds that bind to p185 and methods of using the same
12/09/2010US20100311667 Novel compounds, use thereof in cosmetic and cosmeceutic applications, and compositions comprising same
12/09/2010US20100311666 Cosmetic use of a protein belonging to the ribonuclease family
12/09/2010US20100311665 Method and Composition for Potentiating an Opiate Analgesic
12/09/2010US20100311664 Methods for reducing oxidative damage
12/09/2010US20100311663 Memory influencing protein
12/09/2010US20100311662 Treatment of Acute Coronary Syndrome with an Exendin
12/09/2010US20100311661 Use of compounds derived from cycloheximide for the treatment or prevention of, in particular, ischaemias and cardiopathies
12/09/2010US20100311660 Natriuretic peptide receptor-c agonists
12/09/2010US20100311659 Novel VIII Factors for the Treatment of Type A Hemophilia
12/09/2010US20100311658 Modified vitamin k-dependent polypeptides
12/09/2010US20100311657 Hemoglobin compositions
12/09/2010US20100311656 Treatment or prevention of respiratory viral infections with alpha thymosin peptides
12/09/2010US20100311655 Intranasal carbetocin formulations and methods for the treatment of autism
12/09/2010US20100311654 Modified Polysaccharide-Based Delivery of Nucleic Acids
12/09/2010US20100311653 Splice variants of gdnf and uses thereof
12/09/2010US20100311652 Genetic marker for use in the treatment of leukemia
12/09/2010US20100311651 Use of glp-1 compound for treatment of critically ill patients
12/09/2010US20100311650 Treatment for obesity
12/09/2010US20100311649 Substituted imidazole 4-carboxamides as cholecystokinin-1 receptor modulators
12/09/2010US20100311648 Melanocortin receptor-specific peptides
12/09/2010US20100311647 Use of melanocortins to treat insulin sensitivity
12/09/2010US20100311646 Method of inhibiting clostridium difficile by administration of oritavancin
12/09/2010US20100311645 Proteins from the webs of nephilengys cruentata, avicularia juruensis and parawixia bistriata spiders isolated from brazilian biodiversity
12/09/2010US20100311644 Isozyme-specific antagonists of protein kinase c
12/09/2010US20100311643 Use of glp-1 as a therapeutic agent
12/09/2010US20100311642 Use of v2 receptor antagonists in combination with vaso pressinergic agnosts
12/09/2010US20100311641 Peptide-based body surface coloring reagents
12/09/2010US20100311640 Self-assembling peptide incorporating modifications and methods of use thereof
12/09/2010US20100311639 Inhibitors of ncca-atp channels for therapy
12/09/2010US20100311638 Method for Altering the Shape of Polymer Particles
12/09/2010US20100311595 Lipophilic drug delivery vehicle and methods of use thereof
12/09/2010US20100311189 Novel Receptor Nucleic Acids and Polypeptides
12/09/2010US20100311161 Method for tissue regeneration
12/09/2010US20100311120 Human cytokine receptor
12/09/2010US20100311105 Methods of delivery of exogenous proteins to the cytosol and uses thereof
12/09/2010US20100311075 Human sodium-dependent bile acid transporter proteins
12/09/2010US20100311050 Compositions and methods for the diagnosis and treatment of tumor
12/09/2010US20100311045 Cancer
12/09/2010US20100310710 Methods and compositions for synthesis of long chain polyunsaturated fatty acids
12/09/2010US20100310684 Methods for treating and preventing mucositis
12/09/2010US20100310673 Substance and composition both capable of imparting heat resistance
12/09/2010US20100310669 Dispersion of Poloxamer- Protein Particles, Methods of Manufacturing and Uses Thereof
12/09/2010US20100310665 Bacteriostatic or bacteriocidal compositions and methods
1 ... 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 ... 3163